American International Group Inc. boosted its stake in Cantel Medical Corp. (NYSE:CMD) by 5.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,684 shares of the company’s stock after buying an additional 1,464 shares during the quarter. American International Group Inc. owned approximately 0.07% of Cantel Medical worth $2,701,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of CMD. Parametric Portfolio Associates LLC acquired a new stake in Cantel Medical in the 2nd quarter valued at about $4,820,000. Principal Financial Group Inc. acquired a new stake in shares of Cantel Medical during the 2nd quarter worth approximately $21,919,000. Rhumbline Advisers acquired a new stake in shares of Cantel Medical during the 2nd quarter worth approximately $5,892,000. Koch Industries Inc. acquired a new stake in shares of Cantel Medical during the 2nd quarter worth approximately $407,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Cantel Medical during the 2nd quarter worth approximately $38,718,000. 84.98% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cantel Medical Corp. (NYSE:CMD) opened at $99.50 on Friday. Cantel Medical Corp. has a 1-year low of $69.21 and a 1-year high of $108.00. The company has a current ratio of 2.44, a quick ratio of 1.49 and a debt-to-equity ratio of 0.31. The stock has a market cap of $4,456.71, a P/E ratio of 49.81 and a beta of 1.24.
The business also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be issued a $0.085 dividend. This represents a yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 16th. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. Cantel Medical’s dividend payout ratio (DPR) is 8.19%.
In other Cantel Medical news, Chairman Charles M. Diker sold 20,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $99.15, for a total value of $2,032,575.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $97.55, for a total transaction of $279,773.40. Following the completion of the transaction, the executive vice president now directly owns 39,102 shares of the company’s stock, valued at approximately $3,814,400.10. The disclosure for this sale can be found here. Insiders sold a total of 36,368 shares of company stock valued at $3,576,028 in the last quarter. 12.30% of the stock is owned by insiders.
Separately, Needham & Company LLC restated a “hold” rating on shares of Cantel Medical in a report on Friday, September 1st. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Cantel Medical has a consensus rating of “Hold” and an average price target of $91.67.
Cantel Medical Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.